Bionano Genomics stocks rose by over 14% ($0.81) yesterday, and our robots were quick to spot this opportunity, generating more than a 10% profit on this stock in just one day. We'd like to highlight our Swing Trader Volatility Balanced Strategy v2 TA robot, which is gaining momentum once again.
Introducing our AI robot - the perfect solution for traders seeking a balanced strategy. This advanced technology opens no more than 30 trades at a time, with an average duration of 2 days. We have carefully selected a set of stocks with high and medium volatility, giving traders the flexibility to adjust the algorithms for opening trades based on market activity.
Here's how our AI robot works: it first evaluates short- and medium-term trends for each stock using complex algorithms. Then, using a proprietary set of technical indicators, it looks for a signal to open a trade. Finally, based on the volatility and direction of both types of trends, a separate algorithm determines the position size to be opened.
Once a trade is entered, our AI robot places an order for "Take Profit," with the distance depending on the current market volatility. It uses a stop loss of 3% of the position opening price and a flexible trailing stop to exit positions, enabling traders to save most of the profit if the market reverses.
The robot's trading results are displayed without using margin. To view the full trading statistics and equity chart, click on the "Show More" button on the robot page. Traders can watch live as our AI robot selects equities, enters and exits paper trades on the "Open Trades" tab, while the "Closed Trades" tab provides a complete record of all previous trades made by our AI robot.
To maximize profits, we recommend subscribing to several robots at once. Good luck with your trading!
The RSI Oscillator for BNGO moved out of oversold territory on May 03, 2023. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 39 similar instances when the indicator left oversold territory. In of the 39 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on May 30, 2023. You may want to consider a long position or call options on BNGO as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BNGO just turned positive on May 05, 2023. Looking at past instances where BNGO's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BNGO advanced for three days, in of 191 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNGO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BNGO broke above its upper Bollinger Band on June 01, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BNGO entered a downward trend on May 12, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.021) is normal, around the industry mean (25.146). P/E Ratio (0.000) is within average values for comparable stocks, (142.873). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.647). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (7.657) is also within normal values, averaging (53.441).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BNGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of technologies for analysis of large biological molecules
Industry MedicalSpecialties
A.I.dvisor indicates that over the last year, BNGO has been loosely correlated with PACB. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if BNGO jumps, then PACB could also see price increases.
Ticker / NAME | Correlation To BNGO | 1D Price Change % | ||
---|---|---|---|---|
BNGO | 100% | -3.02% | ||
PACB - BNGO | 65% Loosely correlated | +0.67% | ||
ME - BNGO | 64% Loosely correlated | +1.46% | ||
ESTA - BNGO | 58% Loosely correlated | +0.74% | ||
TWST - BNGO | 56% Loosely correlated | -0.74% | ||
ALGN - BNGO | 55% Loosely correlated | +1.04% | ||
More |